News

­

NPR-C Accelerates Obesity Induced NASH and Potentiates the Development of HCC

AASLD Washington DC October 2017: Prasanna K. Santhekadur, Divya P. Kumar, Kalyani Daita, Mulugeta Seneshaw, Faridoddin Mirshahi, Arun J. Sanyal; Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, VA BACKGROUND. Natriuretic peptide receptor-C (NPR-C) clears circulating natriuretic peptides e. g. ANP by binding and internalization. ANP is decreased and NPR-C expression is increased in [...]

October 27th, 2017|News|0 Comments

The Physiological, Pathological and Molecular Basis of Nonalcoholic Steatohepatitis Associated Cardiomyopathy

 AASLD Washington DC October 2017:  Abdul Oseini1, Stefano Toldo5, Mulugeta Seneshaw1, Divya P. Kumar1, Prasanna K. Santhekadur1, Hae-Ki Min1, Eleonora Mezzaroma5, Pierre Bedossa2, A. Gabriele Mauro5, Federico Quaini3, Caterina Frati3, Angela Falco3, Srinivas Koduru4, Bubu A. Banini1, Faridoddin Mirshahi1, Antonio Abbate5, Oliver Rider6, Mohammad Siddiqui1, Arun J. Sanyal1; 1Division of Gastroenterology, Hepatology and Nutrition, Virginia [...]

October 27th, 2017|News|0 Comments

Sanyal Bio to attend EASL 2018 and will be in the Biotech village

Sanyal Bio to attend the international Liver meeting EASL 2018 in Paris and will be in the Biotech village. The International Liver Congress attracts 11,000 liver experts to meet and discuss latest scientific research. Come to the Biotech village to discuss your pre-clinical needs.  

October 11th, 2017|News|0 Comments

Sanyal Bio to attend AASLD 2017 – visit booth 229

Sanyal Bio attends AASLD 2017 in Washington from Friday, October 20, 2017  to Tuesday, October 24, 2017.  AASLD will see more than 9,500 hepatologists and hepatology health professionals from across the nation and around the world will gather at The Liver Meeting® to exchange the latest liver diseases research, discuss treatment outcomes, and interact with colleagues [...]

October 5th, 2017|News|0 Comments

Immuron Initiates NASH MOA Studies with SanyalBio and with Duke University

MELBOURNE, Australia, Jan. 19, 2017 (GLOBE NEWSWIRE) -- Australian biopharmaceutical Company Immuron Limited (ASX:IMC) is pleased to announce the initiation of several studies designed to add to the growing body of evidence supporting the unique mechanism of action (MOA) of IMM-124E in non-alcoholic steatohepatitis (NASH). The studies will be done in partnership with Sanyal Biotechnology [...]

January 24th, 2017|News|0 Comments

Sanyal Biotechnology Honored as One of the Best University Startups of 2016 by the National Council of Entrepreneurial Tech Transfer (NCET2)

NCET2 is an American organization of university technology transfer officers, and this was the first national startup competition that they sponsored.  Of the 200 startups that competed, Sanyal Biotechnology was one of the finalists chosen to present at DemoDay 2016, an event held in Washington DC at Congress on September 20th.  Dr. Rebecca Caffrey, CEO [...]

August 30th, 2016|News|Comments Off on Sanyal Biotechnology Honored as One of the Best University Startups of 2016 by the National Council of Entrepreneurial Tech Transfer (NCET2)

Sanyal Bio MD publishes on ‘The potential impact of Brexit on UK clinical research’

Industry Viewpoints: The potential impact of Brexit on UK clinical research by Nathan Nagel. Macro environmental market forces are always changing and the BREXIT means significant PESTLE changes to the UK LifeScience and healthcare ecosystems. However, I use the word 'change' not end, as the nation's competitiveness depends on the capacity of its backbone industries to [...]

July 12th, 2016|News|Comments Off on Sanyal Bio MD publishes on ‘The potential impact of Brexit on UK clinical research’

Sanyal Biotechnology relocates its headquarters to Virginia Beach

Sanyal Biotechnology will relocate its headquarters to Virginia Beach in July 2016. The company will take over space at Tidewater Community College’s Wet Lab, pending approval from the Virginia Beach Development Authority, which will also vote on a $25,000 grant for Sanyal. Rebecca Caffrey, the CEO and founder of Sanyal, said that if the company [...]

July 12th, 2016|News|Comments Off on Sanyal Biotechnology relocates its headquarters to Virginia Beach

Dr Arun Sanyal and Dr Rebecca Caffrey at the EASL 2016 international launch of Sanyal Bio

Sanyal Biotechnology made its exceptionally successful international launch at the EASL International Liver Congress™ 2016 (ILC) for the 51st annual meeting of the European Association for the Study of the Liver on the 13-17 April 2016 at the Fira Barcelona Gran Via, Barcelona, Spain.

April 21st, 2016|News|Comments Off on Dr Arun Sanyal and Dr Rebecca Caffrey at the EASL 2016 international launch of Sanyal Bio

Sanyal Biotechnology LLC announces strategic partnership with OWL Metabolomics, S.L.

April 16, 2016 - Richmond, Virginia and Barcelona, Spain: Sanyal Biotechnology LLC and One Way Liver S.L. (OWL Metabolomics) have initiated a strategic partnership to provide increased value and additional R&D services to basic research and the pharmaceutical industry, announced at the International Liver Congress in Barcelona, Spain. Research companies and institutions who utilize Sanyal [...]

April 21st, 2016|News|Comments Off on Sanyal Biotechnology LLC announces strategic partnership with OWL Metabolomics, S.L.